IP
IndiaPulse

EPIGRAL

Small Cap

Epigral Limited

Industrials

Epigral Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹1,147
+29.00 · +2.59%
Quote09 Jun, 10:02 am
Fundamentals08 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags02 May 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Investable fundamentals, management trust is acceptable, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
Good U-Score but weak results consistency: verify latest quarters.
U-Score
UNDERVALUED
73

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
70

low confidence · 0/0 claims checked

Technical
Neutral
54

Timing lens: price trend and sector relative strength.

Result consistency
weak
41

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 31 Mar 2026

Bad · 2/100

PAT -7% YoY · margin compression · Rev +17% YoY · +23% QoQ

Filed 02 May 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹736 Cr+17.2%+23.3%
EBITDA₹168 Cr-2.9%+63.1%
Operating margin23.0%-500 bps+600 bps
PAT₹81 Cr-6.9%+107.7%
PAT margin11.0%-284 bps+448 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Issuer presentation review pending

Epigral Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Technical timing lens

Trend score and candlestick chart

54Neutral

SMA20 +7.4% / mo

Stock trend: 57
Sector RS: 51
Sector 3M: +0.4% vs Nifty +0.1%

Technical chart

EPIGRALweekly · 3Y-45.4%
Latest close ₹1149.70 on 2026-06-09
Bar
-0.5%
RSI
46
MACD hist
3.25
52W pos
28%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹739₹1.1k₹1.5k₹1.9k₹2.2k52H52L2024-122025-032025-062025-092025-122026-03Vol2024-112025-042025-102026-032026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Bullish setup

Trend is constructive — long-term trend unclear. RSI 46.

  • SMA20 rising (~6.9% over last month) — short-term momentum positive.
  • RSI(14) at 46 — rising, no extreme reading.
  • MACD above signal but histogram contracting — bullish momentum cooling.
  • 44% off 52W high · 42% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

73U-SCORE
Top Setup

Fundamental score breakdown

UNDERVALUED
Valuation19/30
Growth22/25
Quality11/20
Balance Sheet11/15
Cash Flow5/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
73

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

73/100 · UNDERVALUED

Positive drivers

  • Piotroski is strong at 8/9.
  • Fair-value margin of safety is positive at 66.9%.
  • Growth contributes 22/25 to the score.

Main drags

  • Cash flow is weaker at 5/10; verify the latest quarterly trend.
  • Quality is weaker at 11/20; verify the latest quarterly trend.
  • Valuation is weaker at 19/30; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
14.6
PB
2.2
EV/EBITDA
7.3
ROE
16.0%
ROCE
15.5%
FCF Yield
1.7%
Debt/Equity
0.3
MoS
+66.9%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
73
Previous: 74 (-1)
Verdict
UNDERVALUED
Previous: UNDERVALUED
Margin of safety
+66.9%
Previous: +67.7%

Score history

12 stored score snapshots. Latest stored move: +1 points.

08 Jun 2026
v4.2-nightly
73
73
73
73
74
74
74
73
73
73
73
74

Factor attribution

Valuation
19-1
was 20
Trust Score
70Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 64th percentile of the scored universe and 61st percentile within Industrials. Main check: results consistency is weak at 41/100.

Healthy Trust Lite: Promoter holding is 68.8%. Key concern: 2 recent quarters had PAT decline worse than 25% YoY.

Computed 22 May 2026
trust-lite-v1
0 docs indexed · 0 concall links
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
64th percentile

overall median 67 · Industrials: 61st pctile, median 68 · Small: 69th pctile, median 65

Evidence depth
Financial-only

0 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
50
watch · capital discipline
Results
41
weak · quarterly consistency

Trust positives

  • Promoter holding is 68.8%.
  • Promoter pledge is zero.
  • FCF yield is positive at 1.5%.
  • 4 years of positive FCF.

Trust risks

  • 2 recent quarters had PAT decline worse than 25% YoY.
  • ROCE trend is -3.5%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹944.28
-21.5% MoS
DCF Fair PE
45.0
DCF Fair Value
₹3,462.75
+66.9% MoS
PEG
0.54

Fundamentals

Valuation

P/E
14.60
P/B
2.17
EV/EBITDA
7.34
Market Cap
4816.00Cr

Profitability

ROE
16.00%
ROCE
15.50%
ROA
9.47%
Dividend Y
0.45%

Growth (CAGR)

Revenue 5Y
25.00%
EPS 5Y
27.00%
Revenue 3Y
5.00%
EPS 3Y
-2.00%

Balance Sheet

Debt/Equity
0.26
Interest Coverage
7.86×
Altman Z
4.60
Book Value
515.00

Cash Flow

FCF Yield
1.68%
FCF Positive Y
4/5
OCF
436.00 Cr
EPS TTM
76.95

Shareholding

Promoter Hold
68.83%
Promoter Pledge
0.00%
Momentum 52W
24%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
Latest: 2,527-0.9% vs prev
02550Mar 2021: 829Mar 2022: 1,551Mar 2023: 2,188Mar 2024: 2,550Mar 2025: 2,527FY21FY22FY23FY24FY25

Net Profit

₹ Cr
Latest: 358+82.7% vs prev
0358.0Mar 2021: 101Mar 2022: 253Mar 2023: 353Mar 2024: 196Mar 2025: 358FY21FY22FY23FY24FY25

Return on Equity

%
Latest: 18.8+20.4% vs prev
034.9Mar 2021: 21.3%Mar 2022: 34.9%Mar 2023: 33.0%Mar 2024: 15.6%Mar 2025: 18.8%FY21FY22FY23FY24FY25
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.